September 21, 2018 10:32 AM EDTUpdated September 24, 12:58 PM
Peer Review

Ex-Cas­ca­di­an chief Scott My­ers lands at Bio­Clin; Ko­di­ak woos Genen­tech vet Ja­son Ehrlich for CMO role

Amber Tong

→ Scott My­ers and Julie East­land, two of the top ex­ecs head­ed out as Cas­ca­di­an Ther­a­peu­tics got …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Up­dat­ed: Am­gen obe­si­ty shot shows 20% weight loss, but dos­ing ques­tions hang over read­out

Up­dat­ed: Roche buys out CAR-T part­ner Po­sei­da for $1B up­front

Sarep­ta li­cens­es Ar­row­head­'s RNA-based rare dis­ease pipeline, promis­ing big biobucks

Alec­tor says Alzheimer's pro­gram tar­get­ing mi­croglia fails Phase 2, stock dives

Roche’s TIG­IT drug miss­es last shot at sur­vival end­point win in Phase 3 lung can­cer tri­al

How did Trump’s FDA pick land? Biotech stocks are up, and ex­ec­u­tives are (most­ly) re­lieved

A service from the Financial Times